Torrey Pines Law Group Torrey Pines Law GroupFree Consultation
≡
  • About Us
    • About Our Firm
    • The Advantages of Hiring Our Firm
    • Recent Successes
    • Client Testimonials
    • Careers
    • Diversity
    • Locations
    • San Diego
      • San Diego Patent Atorneys
      • San Diego FDA Regulatory Counsel
      • San Diego Technology Transactions
    • Irvine
      • Irvine Patent Atorneys
      • Irvine FDA Regulatory Counsel
      • Irvine Technology Transactions
    • Los Angeles
      • Los Angeles Patent Atorneys
      • Los Angeles FDA Regulatory Counsel
      • Los Angeles Technology Transactions
    • Contact
  • Professionals
    • Meet Our Team
    • Kevin Buckley, JD
    • Edgar Asebey, JD
    • Frank Chen, PhD
    • Nach Davé, MS, RPh
    • Elie Gendloff, PhD, JD
    • Dmitry Kryndushkin, PhD
    • Mark Malek, JD
    • Eleanor Musick, JD
    • Steven Stupp, PhD
    • Neil Thompson, MS
    • Kyle Welch, JD
    • Jian Yang, PhD
    •  
    • Administration
    • Suzanne Baycan
    • Carina Collins
    • Erika Hamer
    • Cyndi Willis
    •  
    • Foreign Associates
  • Intellectual Property
    • Comprehensive IP Protection
    • Patent Preparation & Prosecution
    • ● Artificial Intelligence Patent Lawyers
    • ● Biotechnology Patent Lawyers
    • ● Chemistry & Chemical Engineering Patent Lawyers
    • ● Convergence Technology Patent Lawyers
    • ● Electronics & Software Patent Lawyers
    • ● In Vitro Diagnostics Patent Lawyers
    • ● Medical Device Patent Lawyers
    • ● Pharmaceutical Patent Lawyers
    • ● Pharmaceutical Lifecycle Management
    • National Phase Entry (PCT)
    • IP Litigation
    • IP Opinions & Counseling
    • IP Resources
      • Patent Rights Overview
      • International Patent Law
      • U.S. Patent Law
        • Patent Eligibility
        • Novelty
        • Obviousness
        • Written Description
        • Enablement
      • Anatomy of a U.S. Patent
        • Utility Patent
        • Design Patent
        • Plant Patent
      • Trademark Law
      • Copyright Law
      • Trade Secrets
      • Know How
      • Intangible Assets
  • FDA Regulatory
    • Global Strategic Counseling
    • Dossier Submissions
    • Quality Compliance (ISO)
    • CE Mark - MDR Services
    • Digital Health
    • Hatch-Waxman & Biosimilars
    • Labeling, Advertising & Promotion
    • Reimbursement & Health Economics
  • Tech Transactions
    • International Technology Transactions
    • Intellectual Property Agreements
    • Intellectual Property Due Diligence
    • Regulatory Agreements
    • Regulatory Due Diligence
    • Business Agreements
    • Transactional Due Diligence
    • Corporate Strategy
  • Experience
    • Our International Experience
    • Multinational Companies
    • Public Companies
    • Private Companies
    • Research & Academic Institutions
    • Hospitals & Physicians
    • Startups & Entrepreneurs
background
Hide
 
Show
  • background
  • torrey-pines-broken-hill
  • torrey-pines-sunset

Patent Rights Overview

Patent Rights Overview

What Is a Patent?

A patent for an invention is the grant of a property right to the inventor issued by the United States Patent and Trademark Office. Generally, the term of a new patent is 20 years from the date on which the application for the patent was filed in the United States or, in special cases, from the date an earlier related application was filed. To maintain the 20 year term, the patent owner must pay maintenance fees at certain intervals. U.S. patents are effective only within the United States, U.S. territories, and U.S. possessions. Under certain circumstances, patent term extensions or adjustments may be available.

The legal right provided by the patent is, in the language of the patent statute, “the right to exclude others from making, using, offering for sale, or selling” the invention in the United States or “importing” the invention into the United States. What is granted is not the right to make, use, offer for sale, sell or import, but the right to exclude others from making, using, offering for sale, selling or importing the invention. Once a patent is issued, the patentee must enforce the patent without aid of the USPTO.

There are three types of patents:

  1. Utility patents may be granted to anyone who invents or discovers any new and useful process, machine, article of manufacture, or composition of matter, or any new and useful improvement thereof;
  2. Design patents may be granted to anyone who invents a new, original, and ornamental design for an article of manufacture; and
  3. Plant patents may be granted to anyone who invents or discovers and asexually reproduces any distinct and new variety of plant.
≡
  • Comprehensive IP Protection
  • Patent Preparation & Prosecution
  • ● Artificial Intelligence Patent Lawyers
  • ● Biotechnology Patent Lawyers
  • ● Chemistry & Chemical Engineering Patent Lawyers
  • ● Convergence Technology Patent Lawyers
  • ● Electronics & Software Patent Lawyers
  • ● In Vitro Diagnostics Patent Lawyers
  • ● Medical Device Patent Lawyers
  • ● Pharmaceutical Patent Lawyers
  • ● Pharmaceutical Lifecycle Management
  • National Phase Entry (PCT)
  • IP Litigation
  • IP Opinions & Counseling
  • IP Resources
    • Patent Rights Overview
    • International Patent Law
    • U.S. Patent Law
      • Patent Eligibility
      • Novelty
      • Obviousness
      • Written Description
      • Enablement
    • Anatomy of a U.S. Patent
      • Utility Patent
      • Design Patent
      • Plant Patent
    • Trademark Law
    • Copyright Law
    • Trade Secrets
    • Know How
    • Intangible Assets

Torrey Pines Law Group, PC BBB Business Review Torrey Pines Law Group LinkedIn COPYRIGHT © , TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP | PAYMENTS | STANDARD FIRM CHARGES

Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.

We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.